Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
about
Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.Clinical relevance and current challenges of research on disseminating tumor cells in cancer patientsPersistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsDisseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyThe presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patientsPredicted trends in long-term breast cancer survival in England and Wales.The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients.Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic diseaseComparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.Natural and Induced Humoral Responses to MUC1.Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.Synchronous breast cancer and alveolar rhabdomyosarcoma bone marrow metastases
P2860
Q33320704-7871902E-3644-4D18-9D50-6A62451FD485Q33555492-7D3BE50D-75AE-439C-A0D0-141862F57EFEQ34284264-7C9557C6-C68F-407D-830C-08018E5FAD9FQ34468675-9879A87F-3215-4AC9-A218-7D487D028141Q34520174-7D4BFA21-6BBB-43F9-9AFE-8CB9D8DDB851Q35681975-EF6001F8-ED66-4549-BF81-ECCDF35ED381Q35694373-B24A3998-9B40-4FB4-8A05-B09AA61C7720Q36001170-334151C8-F3D6-4C4D-AB42-8DE9150CDBD0Q36610179-2568E446-8A7F-42E1-ACB3-CE190B55704DQ36611069-7AC4E613-B745-4446-BB4C-2F8429670AB3Q36613930-BC461B9C-9D9B-4F53-85B8-4426BCF39A4BQ36930838-87D8CB94-B23F-462B-B080-8366D93FFB99Q36974719-DC1392CF-F570-40BA-A42A-983195560F6DQ37036125-B14147F7-1FAD-4BE5-899C-A4DFE446C82AQ37081015-C0DDD5C9-F307-4869-8BA3-C2CCE42416D2Q37137385-460ED9D5-DFCE-45DD-860C-1B0D334657B7Q37885239-951162C8-942C-419C-9184-A4468D76A143Q37898107-5154D8F5-6DFE-472F-BF01-BD611340B32EQ39498742-7FB41834-46F6-4A8F-9653-6328C4ADA1F1Q53649488-1FD16560-4FE7-47B8-BC05-1B63859102FDQ55364776-11D46EEC-0D4D-4E5A-A500-4FEE4E0935DAQ57113518-62DB2C0A-98B0-44BC-9DA9-8F1A6A007ADA
P2860
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@en
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@nl
type
label
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@en
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@nl
prefLabel
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@en
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@nl
P2093
P2860
P356
P1476
Persistence of bone marrow mic ...... st cancer: results at 4 years.
@en
P2093
Anjana Singh
Brendan M Smith
Clare Peckitt
Gopi Tripuraneni
H Dudley Sinnett
Helen Graham
Margreet Lüchtenborg
Martin J Slade
R Charles Coombes
Samantha Fox
P2860
P304
P356
10.1002/IJC.20655
P577
2005-03-01T00:00:00Z